Matches in SemOpenAlex for { <https://semopenalex.org/work/W2719086851> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W2719086851 endingPage "5861" @default.
- W2719086851 startingPage "5861" @default.
- W2719086851 abstract "Abstract Objective:Autoimmune hematological diseases (AHDs) occur more frequently than other autoimmune complications after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and are often refractory to treatment. The aim of this study was to analyze the incidence and risk factors of AHDs as well as its response to treatment in a series of patients undergoing allo-HSCT at our single institution. Method:Forty hundred and forty-five adult malignant hematopoietic disorders underwent allo-HSCT were enrolled in this retrospective study, including 181 cases underwent HLA-matched sibling donor (MSD) transplants, 140 unrelated donor (MUD) transplants and 124 haploidentical donor transplants (HRD). Result:Twelve patients developed AHDs, including 6 autoimmune hemolytic anemia (AIHA)and 6 Evans' syndrome.The median time of AHDs onset was 196 days (range, 60-756). Evans' syndrome all ocuured in HRD. The 3-year cumulative incidence of AHDs was 2.7%,and HRD had higher incidence than MSD (6.5% vs 1.1%,P=0.017) and MUD(6.5%vs1.4%,P=0.049). Eight of them received complete response (CR) and 3 no response (NR) after 11 patients received the corticosteroids combined with CSA as the initial treatment for 4 weeks. One obtained CR and 2 PR after 3 NR cases treated by rituximab. Eleven cases all not were AHDs recurrence at a median followup of 313 days (range, 153 to 1051 days after CR. HRD transplantation(vs MSD: hazard ratio [HR], 7.70; 95% confidence interval [CI], 1.63 to 36.44; P=.01 and vs MUD: hazard ratio [HR], 5.87; 95% confidence interval [CI], 1.24 to 27.73; P=.026) and concurrent chronic GVHD (hazard ratio [HR], 3.76; 95% confidence interval [CI], 1.18 to 11.92; P=.025)were risk factors for AHDs. Conclusion:The patients undergoing HRD transplantation had higher risk of AHDs and manifested as Evan's syndrome was very common compared with MSD and MUD. Corticosteroids combined with CSA as the first line treatment of AHDs results in good response and low recurrence rate. Disclosures Lin: National Natural Science Foundation of China 81400141: Research Funding; National Natural Science Foundation of China 81270647: Research Funding; Science and technology planning project of Guangdong Province 2014B020226004: Research Funding; The project of health collaborative innovation of Guangzhou City 201400000003-4: Research Funding." @default.
- W2719086851 created "2017-06-30" @default.
- W2719086851 creator A5000828146 @default.
- W2719086851 creator A5010298865 @default.
- W2719086851 creator A5015598681 @default.
- W2719086851 creator A5015810394 @default.
- W2719086851 creator A5029592269 @default.
- W2719086851 creator A5032457247 @default.
- W2719086851 creator A5034407018 @default.
- W2719086851 creator A5041183580 @default.
- W2719086851 creator A5042449700 @default.
- W2719086851 creator A5053447705 @default.
- W2719086851 creator A5067670661 @default.
- W2719086851 creator A5077083856 @default.
- W2719086851 date "2016-12-02" @default.
- W2719086851 modified "2023-10-16" @default.
- W2719086851 title "Autoimmune Hematological Diseases Following Haploidentical Donor Hematopoietic Stem Cell Transplant Compared with Matched Sibling and Unrelated Donor" @default.
- W2719086851 doi "https://doi.org/10.1182/blood.v128.22.5861.5861" @default.
- W2719086851 hasPublicationYear "2016" @default.
- W2719086851 type Work @default.
- W2719086851 sameAs 2719086851 @default.
- W2719086851 citedByCount "0" @default.
- W2719086851 crossrefType "journal-article" @default.
- W2719086851 hasAuthorship W2719086851A5000828146 @default.
- W2719086851 hasAuthorship W2719086851A5010298865 @default.
- W2719086851 hasAuthorship W2719086851A5015598681 @default.
- W2719086851 hasAuthorship W2719086851A5015810394 @default.
- W2719086851 hasAuthorship W2719086851A5029592269 @default.
- W2719086851 hasAuthorship W2719086851A5032457247 @default.
- W2719086851 hasAuthorship W2719086851A5034407018 @default.
- W2719086851 hasAuthorship W2719086851A5041183580 @default.
- W2719086851 hasAuthorship W2719086851A5042449700 @default.
- W2719086851 hasAuthorship W2719086851A5053447705 @default.
- W2719086851 hasAuthorship W2719086851A5067670661 @default.
- W2719086851 hasAuthorship W2719086851A5077083856 @default.
- W2719086851 hasBestOaLocation W27190868511 @default.
- W2719086851 hasConcept C120665830 @default.
- W2719086851 hasConcept C121332964 @default.
- W2719086851 hasConcept C126322002 @default.
- W2719086851 hasConcept C141071460 @default.
- W2719086851 hasConcept C203014093 @default.
- W2719086851 hasConcept C207103383 @default.
- W2719086851 hasConcept C2777385706 @default.
- W2719086851 hasConcept C2777408962 @default.
- W2719086851 hasConcept C2778248108 @default.
- W2719086851 hasConcept C2779338263 @default.
- W2719086851 hasConcept C2780653079 @default.
- W2719086851 hasConcept C2781128166 @default.
- W2719086851 hasConcept C2911091166 @default.
- W2719086851 hasConcept C44249647 @default.
- W2719086851 hasConcept C61511704 @default.
- W2719086851 hasConcept C71924100 @default.
- W2719086851 hasConcept C88879693 @default.
- W2719086851 hasConcept C90924648 @default.
- W2719086851 hasConceptScore W2719086851C120665830 @default.
- W2719086851 hasConceptScore W2719086851C121332964 @default.
- W2719086851 hasConceptScore W2719086851C126322002 @default.
- W2719086851 hasConceptScore W2719086851C141071460 @default.
- W2719086851 hasConceptScore W2719086851C203014093 @default.
- W2719086851 hasConceptScore W2719086851C207103383 @default.
- W2719086851 hasConceptScore W2719086851C2777385706 @default.
- W2719086851 hasConceptScore W2719086851C2777408962 @default.
- W2719086851 hasConceptScore W2719086851C2778248108 @default.
- W2719086851 hasConceptScore W2719086851C2779338263 @default.
- W2719086851 hasConceptScore W2719086851C2780653079 @default.
- W2719086851 hasConceptScore W2719086851C2781128166 @default.
- W2719086851 hasConceptScore W2719086851C2911091166 @default.
- W2719086851 hasConceptScore W2719086851C44249647 @default.
- W2719086851 hasConceptScore W2719086851C61511704 @default.
- W2719086851 hasConceptScore W2719086851C71924100 @default.
- W2719086851 hasConceptScore W2719086851C88879693 @default.
- W2719086851 hasConceptScore W2719086851C90924648 @default.
- W2719086851 hasIssue "22" @default.
- W2719086851 hasLocation W27190868511 @default.
- W2719086851 hasOpenAccess W2719086851 @default.
- W2719086851 hasPrimaryLocation W27190868511 @default.
- W2719086851 hasRelatedWork W1965781942 @default.
- W2719086851 hasRelatedWork W1987906963 @default.
- W2719086851 hasRelatedWork W2010701770 @default.
- W2719086851 hasRelatedWork W2538699508 @default.
- W2719086851 hasRelatedWork W2590194097 @default.
- W2719086851 hasRelatedWork W2719086851 @default.
- W2719086851 hasRelatedWork W2793697885 @default.
- W2719086851 hasRelatedWork W2966674864 @default.
- W2719086851 hasRelatedWork W2994459064 @default.
- W2719086851 hasRelatedWork W4313529758 @default.
- W2719086851 hasVolume "128" @default.
- W2719086851 isParatext "false" @default.
- W2719086851 isRetracted "false" @default.
- W2719086851 magId "2719086851" @default.
- W2719086851 workType "article" @default.